LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.98 | 17.25 | 862 | 445 | 1.9368 | 1.3028 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.98 | 17.25 | 875 | 445 | 1.9660 | 1.3101 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.95 | 17.25 | 901 | 471 | 1.9106 | 1.2906 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.95 | 17.25 | 901 | 471 | 1.9106 | 1.2906 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.91 | 17.25 | 913 | 494 | 1.8450 | 1.2697 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.91 | 17.25 | 911 | 494 | 1.8409 | 1.2686 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 14.88 | 17.25 | 952 | 534 | 1.7813 | 1.2473 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 14.88 | 17.25 | 954 | 534 | 1.7851 | 1.2482 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 16.85 | 17.25 | 57 | 655 | 0.0869 | 0.2558 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 16.85 | 17.25 | 983 | 655 | 1.4995 | 1.1605 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 16.85 | 17.25 | 22 | 655 | 0.0336 | 0.0474 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 16.85 | 17.25 | 991 | 655 | 1.5117 | 1.1638 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 18.82 | 17.25 | 98 | 800 | 0.1224 | 0.3686 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 18.82 | 17.25 | 1027 | 800 | 1.2829 | 1.0921 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 18.82 | 17.25 | 34 | 800 | 0.0425 | 0.1304 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 18.82 | 17.25 | 1015 | 800 | 1.2680 | 1.0876 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 20.79 | 17.25 | 292 | 1001 | 0.2915 | 0.6206 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 20.79 | 17.25 | 1078 | 1001 | 1.0762 | 1.0252 | MN20160310_N02 | L07 |